The purpose of the study is to determine whether the continuing detection of cell-free plasma tumor DNA (ptDNA), circulating tumor cells (CTCs), and cytokines (chemicals that help the immune system communicate) in the blood can help to better evaluate the status of a patients cancer over the course of therapy.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Patrick Thompson
Pediatrics - Hematology/Oncology
Clinical or Medical
Observational
Cancer (Pediatric Cancers, Sarcoma (bone and soft tissue))
20-1738
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
